• Skip to content
  • Skip to navigation
  • Skip to footer
AstraZeneca logo AstraZeneca logo
AstraZeneca logo AstraZeneca logo
  • What science can do
  • R&D
    • R&D
    • Our approach
    • Transformative science
    • Data science & AI
    • Digital health
    • Our technologies
    • Next generation therapeutics
    • Publications
    • R&D strategic centres
  • Our therapy areas
    • All therapy areas
    • Oncology
    • BioPharmaceuticals
    • Cardiovascular, Renal and Metabolism
    • Respiratory & Immunology
    • Other disease areas
    • Pipeline
    • All medicines
  • Our company
    • Our company
    • Our strategy
    • Our people
    • Our commitment to patients
    • Our leadership
    • Cambridge
    • Gothenburg
    • Gaithersburg
  • Careers
  • Investors
    • Investor Relations (Global) UK flag
    • Investor Relations (Sweden) Swedish flag
    • Resources
    • Governance
    • Shareholder information
    • Dividend policy
    • Key facts
    • FAQs
    • Debt Investors
    • ADR Programme
  • Media
    • Press Releases
    • Media centre
    • Statements
    • Articles
    • Image library
    • COVID-19 resources
    • Broadcast videos
    • Archive
    • Media contacts
  • Sustainability
    • Sustainability
    • Access to healthcare
    • Environmental protection
    • Ethics and transparency
    • Partnerships, alliances and recognition
    • Supporting our communities
    • Resources
  • Partnering
    • Partnering with AstraZeneca
    • Our Partnering teams
    • Our areas of partnering interest
    • Why partner with AstraZeneca?
    • Secrets to successful partnering
    • Supplier Information
    • A Catalyst Network
  • AstraZeneca Websites
  • Global site

Resources

View global sites

View site map

Scientists

What science can do
OpenInnovation
AZ Neuro
LabTalk blog
Gothenburg BioVentureHub
Partner with us


Medicines

Oncology
Cardiovascular, Renal and Metabolism
Respiratory & Immunology
Other disease areas
All medicines


Clinical trials

Global clinical trials information


Patients

Visit your local AstraZeneca site for more information
USA prescription assistance programmes
Early access to AstraZeneca investigational medicinal products 


Careers

Careers at AstraZeneca
Join us in Cambridge
Information for students


Social media

Twitter (global)
Twitter (careers)
LinkedIn
Facebook
YouTube


AstraZeneca Websites

This website is intended for people seeking information on AstraZeneca's worldwide business. Our country sites can be located in the AZ Network.


Veeva ID: Z4-25396
Date of next review: August 2022

Resources

  • All resources
  • Open Innovation
  • Externally sponsored scientific research
  • Medical Information for HCPs
  • US prescription assistance programmes
  • Global clinical trials information
  • Medicines
  • Report a possible side effect

Quick links

  • Media
  • Investor Relations
  • Partnering
  • Careers
  • Sustainability
  • Modern Slavery Statement
  • AZethics – Report A Concern
  • Supplier information
  • Social Media Community Guidelines

Social Media

  • LinkedIn
  • Twitter
  • YouTube
  • Instagram
  • Glassdoor
  • Facebook

utility links

  • Legal notice and Terms of Use
  • Privacy notice
  • Site map
  • Contact us
  • Cookie policy

© AstraZeneca 2022

You are now leaving AstraZeneca.com

You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.

AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit.

Click ‘cancel’ to return to AstraZeneca’s site or ‘continue’ to proceed.

Cancel Continue
?

Important notice for users

You are about to access AstraZeneca historic archive material. Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.

I disagree I agree
?
?